Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vericel Corporation (NQ: VCEL ) 52.39 -0.51 (-0.96%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 269,600 Open 52.38 Bid (Size) 48.00 (1) Ask (Size) 55.11 (2) Prev. Close 52.90 Today's Range 52.02 - 53.85 52wk Range 30.18 - 53.85 Shares Outstanding 46,631,158 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer July 22, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024 July 18, 2024 From Vericel Corporation Via GlobeNewswire Performance YTD +50.20% +50.20% 1 Month +13.42% +13.42% 3 Month +13.62% +13.62% 6 Month +28.34% +28.34% 1 Year +40.08% +40.08% More News Read More A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts July 16, 2024 Via Benzinga Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Via Talk Markets Critical Insights From Vericel Analyst Ratings: What You Need To Know May 09, 2024 Via Benzinga Analyst Scoreboard: 5 Ratings For Vericel March 26, 2024 Via Benzinga A Closer Look at 4 Analyst Recommendations For Vericel March 01, 2024 Via Benzinga The 3 Highest-Rated Medical Stocks You Can Buy Today June 27, 2024 Via InvestorPlace Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024 June 11, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 May 22, 2024 From Vericel Corporation Via GlobeNewswire VCEL Stock Earnings: Vericel Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Earnings Scheduled For February 29, 2024 February 29, 2024 Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know January 16, 2024 Via Benzinga Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance May 08, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024 April 24, 2024 From Vericel Corporation Via GlobeNewswire It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility March 11, 2024 Via Talk Markets Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance February 29, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 February 27, 2024 From Vericel Corporation Via GlobeNewswire 3 Top Pharma Stocks for Investors Betting on a Biotech Boom February 26, 2024 Via InvestorPlace Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024 February 15, 2024 From Vericel Corporation Via GlobeNewswire 5 medical stocks growing earnings by triple digits February 06, 2024 Via MarketBeat Topics Economy Exposures Economy Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024 February 05, 2024 From Vericel Corporation Via GlobeNewswire Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session January 23, 2024 Via Investor Brand Network Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results January 09, 2024 From Vericel Corporation Via GlobeNewswire Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 January 03, 2024 From Vericel Corporation Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
